Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.77 USD | -0.77% | -1.82% | +50.60% |
Sales 2024 * | 1.88B 179M | Sales 2025 * | 3.21B 306M | Capitalization | 11.02B 1.05B |
---|---|---|---|---|---|
Net income 2024 * | -62M -5.9M | Net income 2025 * | 1.13B 107M | EV / Sales 2024 * | 5.96 x |
Net Debt 2024 * | 154M 14.67M | Net cash position 2025 * | 1.11B 106M | EV / Sales 2025 * | 3.09 x |
P/E ratio 2024 * |
73.5
x | P/E ratio 2025 * |
10.3
x | Employees | 219 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.3% |
Latest transcript on Calliditas Therapeutics AB
1 day | -0.77% | ||
1 week | -1.82% | ||
Current month | -3.05% | ||
1 month | +71.62% | ||
3 months | +72.69% | ||
6 months | +86.84% | ||
Current year | +50.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 17-05-17 | |
Director of Finance/CFO | 47 | 17-07-31 | |
Chief Tech/Sci/R&D Officer | 60 | 20-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 23-05-29 |
Henrik Stenqvist
BRD | Director/Board Member | 57 | 21-12-31 |
Elmar Schnee
CHM | Chairman | 65 | 19-05-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 38.77 | -0.77% | 4,268 |
24-06-13 | 39.07 | +0.44% | 12,391 |
24-06-12 | 38.9 | +0.34% | 24,489 |
24-06-11 | 38.77 | -1.85% | 11,285 |
24-06-10 | 39.5 | +0.03% | 13,170 |
Delayed Quote Nasdaq, June 14, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.36% | 80.64B | |
+15.93% | 9.07B | |
+42.06% | 4.68B | |
-22.01% | 4.53B | |
+8.28% | 4.06B | |
-26.61% | 2.21B | |
+11.22% | 2.19B | |
+11.64% | 2B | |
-42.69% | 1.82B |
- Stock Market
- Equities
- CALTX Stock
- CALT Stock